Balance Sheet
Cash Flow Statement
AcquisitionsAmortization of GoodwillAsset Writedowns and ImpairmentCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in CashChange in InventoryChange in ReceivablesDepreciation & Amortization (CF)Depreciation and DepletionDivestmentsExchange Rate EffectFree Cash FlowNet Cash FlowNet IncomeOther Working Capital ChangesSales of Property, Plant and EquipmentShare-based CompensationShares Issued
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Avanos Medical (AVNS) Short-Term Debt issuances (2020 - 2024)

Avanos Medical's Short-Term Debt issuances history spans 5 years, with the latest figure at $20.0 million for Q1 2024.

  • For Q1 2024, Short-Term Debt issuances changed N/A year-over-year to $20.0 million; the TTM value through Dec 2024 reached $20.0 million, down 63.64%, while the annual FY2024 figure was $20.0 million, 63.64% down from the prior year.
  • Short-Term Debt issuances for Q1 2024 was $20.0 million at Avanos Medical, down from $55.0 million in the prior quarter.
  • Across five years, Short-Term Debt issuances topped out at $185.0 million in Q4 2020 and bottomed at $20.0 million in Q3 2021.
  • The 5-year median for Short-Term Debt issuances is $37.5 million (2021), against an average of $71.7 million.